EMA fast-tracks Marinus Pharma’s rare epilepsy treatment
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has approved Marinus Pharmaceuticals’ request for accelerated assessment ...
Continue Reading →
